This study determines whether different forms of ketones supplemented prior to a meal lower the triglyceride (fat) content in the blood of overweight and obese individuals. Through a randomized crossover design, participants (n=15) will participate in each of the following three experimental groups (no treatment control, ketone ester, ketone salt), with a 5-14 day washout period between each experimental visit.
Previous studies conducted by the investigative team in rodents show that male mice fed a diet containing 30% ketone ester (by kcals) results in greater fecal content and energy loss. While the investigators are unsure of the exact macronutrient content of the energy loss, the hypothesis is that the energy excretion is attributed to lower fat absorption. In the context of this study, it's hypothesized that ketone salts and ketone esters (both available commercially and used for a variety of health-related claims) will reduce the absorption of dietary fats leading to lower circulating triglyceride concentrations if consumed prior to a high-fat mixed meal. If the hypothesis is correct, ketones supplementation could become a valuable strategy to reduce the rise in circulating triglycerides often present in obesity. Triglyceride concentrations in the blood following a meal have been linked to development of cardiovascular disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
This arm receives 25 g ketone ester.
This arm receives 25 g ketone salt.
Change from baseline plasma glucagon-like peptide 1 at 240 minutes
Plasma levels of glucagon-like peptide 1 in pg/L
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
Change from baseline serum triglycerides at 240 minutes
Serum levels of triglycerides in mg/DL
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
Change from baseline serum glucose at 240 minutes
Serum levels of glucose in mg/dL
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
Change from baseline serum Insulin at 240 minutes
Serum levels of insulin in pmol/L
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
Change from baseline serum B-hydroxybutyrate at 240 minutes
Serum levels of B-hydroxybutyrate in mmol/L
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
Change from baseline plasma ghrelin at 240 minutes
Plasma levels of ghrelin in pg/mL
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
Change from baseline plasma leptin at 240 minutes
Plasma levels of leptin in ng/mL
Time frame: 0, 30, 60, 120, 180, and 240 minutes post-supplement consumption
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.